Krsnaa Diagnostics Ltd. Investor Presentation

Pursuant to Regulation 30 of the Securities and Board of India (Listing Obligation and Disclosure Requirements), 2015, we are enclosing herewith a copy of the presentation for the Investor/Analysts on Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2024.

pdf

Krsnaa Diagnostics Ltd.

12 Feb 2024

754.80

5.46%

Investor Presentation

Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Investor Presentation.

pdf

Krsnaa Diagnostics Ltd.

04 Nov 2023

754.80

5.46%

Investor Presentation

Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Enclosed Investor Presentation for Q2&H1FY24

pdf

Krsnaa Diagnostics Ltd.

14 Aug 2023

754.80

5.46%

Investor Presentation

Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2023

pdf

Krsnaa Diagnostics Ltd.

28 May 2023

754.80

5.46%

Investor Presentation

Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith an Earnings Presentation on Audited Financial Results of the Company for quarter and year ended on 31st March, 2023.

pdf

No results found

Krsnaa Diagnostics Ltd. Investor Presentation

Krsnaa Diagnostics Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more